1. Introduction
===============

Marine soft corals are an excellent source of secondary metabolites with novel structures and interesting biological functions \[[@B1-marinedrugs-12-03477],[@B2-marinedrugs-12-03477],[@B3-marinedrugs-12-03477],[@B4-marinedrugs-12-03477],[@B5-marinedrugs-12-03477]\]. Members of the genus *Cespitularia*, along with morphologically similar *Xenia* species, inhabit the coral reefs along the coasts of Taiwan. These interesting cnidarians have brilliant colors and their outer layers are covered with thick mucilage. Previously, several members of the genus *Cespitularia* were reported to contain a series of complex terpenoids, including cespitularins, nitrogen-containing diterpenoids, cespihypotins, cespitulins and cespitulactones \[[@B6-marinedrugs-12-03477],[@B7-marinedrugs-12-03477],[@B8-marinedrugs-12-03477],[@B9-marinedrugs-12-03477],[@B10-marinedrugs-12-03477],[@B11-marinedrugs-12-03477],[@B12-marinedrugs-12-03477]\]. These diterpenoids are thought to be derived from geranylgeranyl pyrophosphate and 1S-verticillene, involving interesting biogenetic pathways similar to those that generate the taxane diterpenes \[[@B13-marinedrugs-12-03477],[@B14-marinedrugs-12-03477],[@B15-marinedrugs-12-03477]\]. To explore novel bioactive metabolites from these invertebrates, we continued our study on *Cespitularia taeniata*, and have now isolated two novel diterpenoids, designated as cespitulones A (**1**) and B (**2**) ([Figure 1](#marinedrugs-12-03477-f001){ref-type="fig"}). Both compounds possess an unprecedented bicyclo \[10.3.1\] skeleton. Here we report the isolation, structural elucidation, plausible biogenetic pathway, and the cytotoxicity of **1** and **2**.

![Cespitulones A (**1**) and B (**2**) isolated from soft coral *Cespitularia taeniata*.](marinedrugs-12-03477-g001){#marinedrugs-12-03477-f001}

2. Results
==========

Cespitulone A (**1**) was obtained as an amorphous solid that analyzed by HRESIMS for the molecular formula C~20~H~30~O~5~, having six degrees of unsaturation. The presences of hydroxyl and carbonyl functions were indicated by IR absorptions at 3419 and 1703 cm^−1^. The ^1^H- and ^13^C NMR spectra ([Table 1](#marinedrugs-12-03477-t001){ref-type="table"}), along with DEPT NMR data, confirmed the presence of two carbonyls (δ~C~ 212.4 and 207.4), and illustrated a trisubstituted olefin (δ~C~ 131.7 CH, 133.6 C; δ~H~ 5.58 d, *J* = 9.1 Hz), a 1,1-disubstituted olefin (δ~C~ 144.9) with an exomethylene group (δ~C~ 115.5 CH~2~; δ~H~ 4.87s, 4.92s), and one aliphatic quaternary carbon (δ~C~ 45.6, C-15). In addition, two oxygenated methine carbons (δ~C~ 69.8 CH, 77.4 CH), an oxygenated tertiary carbon 34.3 and δ~C~ 24.6), and three methyl groups (δ~C~ 26.9, 27.2, (δ~C~ 89.1 C), six methylene carbons (δ~C~ 31.5, 38.7, 46.9, 47.7, 18.6) with their corresponding proton chemical shifts (δ~H~ 1.54, 1.32, 1.88) were observed. Since **1** contained two carbonyls and two double bonds, the carbon framework of cespitulone A must be bicyclic. Analysis of the COSY NMR data for **1** established the connectivities of H-9/H-9, Me-19/H-7/H-6, H-6/H-5/H-18/H-3/H-2/H-1 and H-13/H-14/H-1. These coupled with the HMBC NMR correlations of H-20/C-10, C-11, C-12, and H-9/C-10, and H-13/C-12, allowed the positions of the carbonyls at C-10 and C-12 and the hydroxyl at C-20 to be assigned. Thus, C-20 could be positioned between the C-10 carbonyl and the tertiary oxygenated C-11 carbon. This suggested that **1** contains an unusual bicyclic system in which the C-20 methyl group (as in cespitularines) was somehow modified and incorporated into the ring system. Analysis of other HMBC correlations, including Me-16/C-11, C-15; Me-17/C-11, C-15; H-9/C-7, C-8 as well as H-5/C-4, C-6, C-18, allowed the proposed bicyclo \[10.3.1\] ring system to be assigned ([Figure 2](#marinedrugs-12-03477-f002){ref-type="fig"}). The relative configuration of **1** was determined by analysis of NOESY NMR data based upon the assumption that **1** has the same absolute C-1 (H-1β) configuration as that of the *Cespitularia*-derived cespitulactams, cespitularines, cespihypotins and toxoids \[[@B16-marinedrugs-12-03477],[@B17-marinedrugs-12-03477]\].

marinedrugs-12-03477-t001_Table 1

###### 

^1^H and ^13^C NMR data for **1** ^a^.

  No      δ~H~ (mult, *J*, Hz) ^b^   δ~C~ ^c^   HMBC             COSY
  ------- -------------------------- ---------- ---------------- --------
  1       1.54 (m)                   45.3       11, 15, 16       2, 14
  2       1.10 (m), 1.46 (m)         31.5       1                1, 3
  3       2.00 (m), 2.23 (m)         38.7                        2, 18
  4                                  144.9                       
  5       2.14 (m), 2.68 (m)         46.9       4, 6, 18         6, 18
  6       4.52 (td, 9.0, 5.5)        69.8       4, 5, 7          7
  7       5.58 (d, 9.0)              131.7                       6, 19
  8                                  133.6                       
  9α      2.63 (d, 14.0)             47.7       6, 7, 8, 10      9b
  9β      4.00 (d, 14.0)                        7, 8, 10, 19     9a
  10                                 212.4                       
  11                                 89.1                        
  12                                 207.4                       
  13      2.77 (m), 2.53 (m)         34.3       12               14
  14      2.00 (m), 1.60 (m)         24.6                        1, 13
  15                                 45.6                        
  16      1.54 (s)                   26.9       1, 11, 15, 17    
  17      1.32 (s)                   27.2       1, 11, 15, 16    
  18      4.87 (s), 4.92 (s)         115.5      3, 5             3, 5
  19      1.88 (s)                   18.6       7, 8, 9          7
  20      4.14 (d, 3.0)              77.4       10, 11, 12, 15   OH
  20-OH   4.30 (d, 3.0)                                          11, 20

^a^ Data were recorded in CDCl~3~ on 500 MHz; chemical shifts (δ) and coupling constants are given in ppm and Hz, respectively; ^b^ Assignments made by COSY and HMQC; ^c^ Assignments made by HMQC and HMBC; Multiplicities determined by DEPT.

The presence of NOESY correlations among H-1/Me-16/Me-17, H-20/Me-16, H-7/Me-17 agreed with β-configuration of Me-16, Me-17 and H-20, while H-6 was assigned an α-configuration on the base of correlations of H-6/Me-19/H-9α and H-7/H-9β ([Figure 2](#marinedrugs-12-03477-f002){ref-type="fig"}). The configuration of the hydroxyl at C-6 was further determined by Mosher's reactions to yield compounds **1a** and **1b** \[[@B18-marinedrugs-12-03477]\]. The results, illustrated in [Figure 3](#marinedrugs-12-03477-f003){ref-type="fig"}, suggested that the C-6 has the *S* configuration. A computer-generated perspective structure for **1** is shown in [Figure 3](#marinedrugs-12-03477-f003){ref-type="fig"} by CS Chem 3D version 9.0 using MM2 force field calculation for energy minimization. The results also suggested that C-6 has S configuration and C-11 hydroxy group is α-oriented.

![Selective HMBC (hook) and NOESY (curve) correlations of **1**.](marinedrugs-12-03477-g002){#marinedrugs-12-03477-f002}

![Mosher's reaction products **1a** and **1b**, which show δ*~S~*--δ*~R~* values (ppm); Computer-generated perspective models for **1** using MM2 force field calculation.](marinedrugs-12-03477-g003){#marinedrugs-12-03477-f003}

Cespitulone B (**2**) was isolated as a colorless amorphous solid. The molecular formula, C~20~H~30~O~5~ (∆ = 6), was determined by HRESIMS with a pseudomolecular ion at *m/z* 373.1993 \[M + Na\]^+^, indicating that it is an isomer of **1**. Analysis of IR bands revealed the presence of hydroxyl (3419 cm^−1^) and carbonyl (1700 cm^−1^) functions. Comparisons of the ^1^H- and ^13^C NMR ([Table 2](#marinedrugs-12-03477-t002){ref-type="table"}) and DEPT data with those of **1** indicated similar functionalities of both compounds. Analysis of COSY and HMBC NMR correlations also revealed similar arrangement of each functional group around the 13-membered ring, including a 1,1-disubstituted olefin (δ~C~ 144.7) with an exomethylene group (δ~C~ 115.5 CH~2~; δ~H~ 4.87 s, 4.95s), a C-6 oxygenated methine carbon (δ~C~ 70.9 CH; δ~H~ 4.57 td, *J* = 9.6, 5.7 Hz), a trisubstituted olefin (δ~C~ 132.1 CH, 135.3 C; δ~H~ 5.54 d, *J* = 9.6 Hz), a C-10 carbonyl carbon (δ~C~ 213.9), a C-20 oxygenated methine carbon (δ~C~ 79.3 CH; δ~H~ 4.46 d, *J* = 3.0 Hz), an oxygenated tertiary carbon (δ~C~ 81.6 C), and the C-15 quaternary carbon (δ~C~ 49.6) with two attached methyl carbons (δ~C~ 24.0 CH3, 27.5 CH3). The positions of two carbonyls at C-10 (δ~C~ 213.9) and C-13 (δ~C~ 212.9) and two hydroxyl groups at C-20 and C-11 were assigned on the basis of HMBC correlations (H-9/C-10, H-20/C-10, C-11, H-12/C-11,C-13, H-14/C-13, Me-16/C-11, and Me-17/C-11). Thus the only difference revealed in comparison with **1** was the location of the C-13 carbonyl group. Analysis of NOESY correlation data \[H-1/Me-16, Me-17, H-20/Me-16, and H-7/Me-17 ([Figure 4](#marinedrugs-12-03477-f004){ref-type="fig"})\], indicated the β-orientation of Me-16, Me-17 and H-20, while H-6 was assigned as α-oriented based upon correlations observed from H-6/Me-19/H-9α and H-7/H-9β. A computer-generated perspective structure for **2** is shown in [Figure 4](#marinedrugs-12-03477-f004){ref-type="fig"}. The results also suggested that C-6 has S configuration and the hydroxyl at C-11 is β-oriented.

marinedrugs-12-03477-t002_Table 2

###### 

^1^H and ^13^C NMR data for **2** ^a^.

  No   δ~H~ (mult, *J*, Hz) ^b^   δ~C~    HMBC            COSY
  ---- -------------------------- ------- --------------- -------
  1    1.32 (m)                   47.6    11,15, 16       2, 14
  2    1.88, 1.93 (m)             34.3    1               1, 3
  3    1.62, 2.26 (m)             40.8                    2, 18
  4                               144.7                   
  5    2.07 (m), 2.81 (m)         47.2    4, 6, 18        6, 18
  6    4.57 (td, 9.6, 5.7)        70.9    4, 5, 7         7
  7    5.54 (d, 9.6)              132.1                   6, 19
  8                               135.3                   
  9α   2.86 (d, 14.0)             48.9    7, 8, 10, 19    
  9β   4.06 (d, 14.0)                                     
  10                              213.9                   
  11                              81.6                    
  12   2.43 (m), 3.33 (m)         35.6    11, 13          
  13                              212.9   12              
  14   1.67 (m), 1.87 (m)         28.2    13              1
  15                              49.6                    
  16   0.77 (s)                   24      1, 11, 15, 17   
  17   1.43 (s)                   27.5    1, 11, 15, 16   
  18   4.87 (s), 4.95 (s)         115.5   3, 5            3, 5
  19   1.99 (s)                   18.8    7, 8, 9         7
  20   4.46 (d, 3.0)              79.3    10, 11, 15      

^a^ Data were recorded in CDCl~3~ on 500 MHz ; chemical shifts (δ) and coupling constants are given in ppm and Hz, respectively; ^b^ Assignments made by COSY and HMQC.

![Key NOESY correlations and computer-generated perspective model for **2** using MM2 force field calculation.](marinedrugs-12-03477-g004){#marinedrugs-12-03477-f004}

[Scheme 1](#marinedrugs-12-03477-f005){ref-type="scheme"} illustrates a plausible biogenetic pathway for **1** and **2** based upon previous publications \[[@B7-marinedrugs-12-03477],[@B8-marinedrugs-12-03477],[@B16-marinedrugs-12-03477]\]. Cespitularin C might be a putative precursor of **1** and **2**. Compound **1** is probably produced via intermediates a, b and c involving steps of epoxydation, rearrangement (1,2 methyl shift), oxidation, ring expansion, hydroxylation. Compound **2** may be derived from the same pathway, but through further hydroxylation, dehydration and ketolization of cation c. The Meinwald type rearrangement may be involved to give a ketone directly in the second step \[[@B19-marinedrugs-12-03477]\].

![Plausible biogenetic pathway of **1** and **2**.](marinedrugs-12-03477-g005){#marinedrugs-12-03477-f005}

The isolated compounds **1** and **2** were evaluated for cytotoxicity against human medulloblastoma (Daoy) and colon adenocarcinoma (WiDr) cancer cell lines. As a result, cespitulone A showed significant *in vitro* cytotoxicity against human medulloblastoma (Daoy) and colon adenocarcinoma (WiDr) cancer cells with IC~50~ values of 8.7 and 6.7 µM, respectively \[[@B20-marinedrugs-12-03477]\]. Mitomycin was used as a positive control with IC~50~ at 0.3 μM.

3. Experimental Section
=======================

3.1. General Experimental Procedures
------------------------------------

Optical rotations were recorded on a JASCO DIP-1000 polarimeter. IR spectra were measured on Hitachi T-2001 spectrophotometer. LRESIMS and HRESIMS were taken on a JEOL JMS-HX 110 mass spectrometer. The ^1^H, ^13^C NMR, ^1^H-^1^H COSY, HMQC, HMBC and NOESY spectra were recorded on Bruker FT-300 (300 MHz for ^1^H) and a Varian UNITY INOVA 500 (500 MHz for ^1^H and 125 MHz for ^13^C) spectrometers. The chemical shifts were given in δ (ppm) and coupling constants in Hz. Silica gel 60 (Merck) was used for column chromatography. Sephadex LH-20 (Amersham Pharmacia Biotech AB, Sweden) was used for separation. LiChrospher^®^ Si 60 (5 μm, 250-10 mm, Merck, Germany) and LiChrospher^®^100 RP-18e (5 μm, 250-10 mm, Merck, Germany) were used for NP-HPLC and RP-HPLC (Hitachi), respectively.

3.2. Extraction and Isolation
-----------------------------

The soft coral (1.1 Kg, freeze-dried), collected at a depth of 20 m in October 2004, was extracted with mixture of CH~2~Cl~2~/EtOH (1:1), and the crude extract was partitioned between EtOAc and H~2~O (1:1). The EtOAc-soluble fraction (100 g) was subjected to a Si gel column (*n*-hexane/EtOAc, 15:1--0:1; EtOAc/MeOH, 50:1--2:1) to give fractions 1-12. Fraction 6 (3.1 g) was chromatographed on a LH-20 Sephadex column (MeOH) and separated further by HPLC column (Si gel, *n*-hexane--CH~2~Cl~2~--MeOH, 20:20:1) to furnish cespitulone A (**1**, 3 mg). Fraction 8 (1.7 g) was further separated on a Sephadex LH-20 column using CH~2~Cl~2~-MeOH(4:1) to give 5 fractions (8-1\~8-5). Fraction 8-4 (779 mg) was further separated with NP-HPLC column (*n*-hexane--CH~2~Cl~2~--MeOH, 20:20:1) and with RP-HPLC column (MeOH--H~2~O--CH~3~CN, 65:30:5) to afford **2** (9 mg).

3.3. Spectroscopic Data
-----------------------

*Cespitulone A* (**1**): amorphous solid, \[α\]^25^~D~ −58.8 (*c* = 0.2, CH~2~Cl~2~); IR (neat) ν~max~ 3419, 2924, 1703 cm^−1^; HRESIMS *m/z* 373.1989 (C~20~H~30~O~5~Na^+^, calcd 373.1991). ^1^H-NMR and ^13^C-NMR (CDCl~3~, 500/125 MHz) see [Table 1](#marinedrugs-12-03477-t001){ref-type="table"} and [Table 2](#marinedrugs-12-03477-t002){ref-type="table"}, respectively.

*Cespitulone B* (**2**): colorless amorphous solid; \[α\]^25^~D~ −63.4 (*c* 0.2, CH~2~Cl~2~); IR (neat) ν~max~ 3419, 2925, 1700, 1445, 1391, 1278 cm^−1^; HRESIMS *m*/*z* 373.1993 (\[M + Na\]^+^, calcd for C~20~H~30~O~5~Na^+^, 373.1991). ^1^H NMR (CDCl~3~) and ^13^C NMR (CDCl~3~) data, see [Table 1](#marinedrugs-12-03477-t001){ref-type="table"} and [Table 2](#marinedrugs-12-03477-t002){ref-type="table"}, respectively.

Preparation of (*S*)- and (*R*)-MPTA esters (**1a** and **1b**) of **1**. To a solution of **1** (0.7 mg in 0.5 mL pyridine) was added *R*-(−)- or *S*-(+)-MPTA chloride (one drop) and the solution was allowed to stand at room temperature for 12 h. After purification using preparative LC, the ester (0.6 mg, 85% yield) was analyzed by ^1^H NMR spectroscopic measurement, and ∆δ = δ*~S~* − δ*~R~* was calculated for **1**.

Compound **1a**: ^1^H NMR (CDCl~3~, 300 MHz) 5.698 (1H, td, *J* = 8.1, 3.0 Hz, H-6), 5.592 (1H, m, H-7), 1.255, 1.384 (6H, s, H-16, -17), 4.922 (1H, s, H-18), 5.041 (1H, s, H-18), 2.000 (3H, s, H-19).

Compound **1b**: ^1^H NMR (CDCl~3~, 300 MHz) 5.655 (1H, td, *J* = 8.1, 3.0 Hz, H-6), 5.399 (1H, d, *J* = 8.1 Hz, H-7), 1.109, 1.486 (6H, s, H-16, -17), 4.926 (1H, s, H-18), 5.050 (1H, s, H-18), 1.975 (3H, s, H-19).

3.4. Cytotoxicity Assay
-----------------------

The cytotoxic activities of compounds against human medulloblastoma (Daoy) and colon adenocarcinoma (WiDr) cancer cell lines cells were assayed by the MTT (3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide) colorimetric assay as previously described \[[@B21-marinedrugs-12-03477]\]. Samples and control standard drugs were prepared at a concentration of 1, 10, 40, and 100 μg/mL. After seeding 2880 cells/well in a 96-well microplate for 3 h, 20 μL of sample or standard agent was placed in each well and incubated at 37 °C for 3 days. After removing the medium from the microplates, the cells were fixed with 10% formaldehyde in 0.9% saline for 30 min, dyed with 1% (w/v) methylene blue in 0.01 M borate-buffer (100 μL/well) for 30 min. The 96-well plate was dipped into a 0.01 M borate-buffer solution four times in order to remove the dye. Then, 100 μL/well of EtOH--0.1 M HCl (1:1) was added as a dye eluting solvent, and the absorbance was measured on a microtiter plate reader (Dynatech, MR 7000) at a wavelength of 650 nm. The ED~50~ value was defined by a comparison with the untreated cells as the concentration of test sample resulting in 50% reduction of absorbance. Mitomycin was used as a standard compound.

4. Conclusions
==============

Our investigation on constituents of Taiwanese soft coral *Cespitularia taeniata* has resulted in the isolation of two novel diterpenoids (**1** and **2**), which possess an unprecedented bicyclo \[10.3.1\] ring system with C-C bond connections between C-10 and C-20, and between C-20 and C-11. Cespitulone A (**1**) exhibited significant cytotoxicity against human medulloblastoma (Daoy) and colon adenocarcinoma (WiDr) cancer cells.
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